Clinical trial

Pilot Evaluation of the Effect of Application Procedure on the Antimicrobial Effects of an Aqueous CHG and a Traditional Iodophor Scrub Paint

Name
060629
Description
Evaluate effect of application procedure on efficacy of 2 antiseptics for cleaning skin prior to surgery.
Trial arms
Trial start
2007-10-01
Estimated PCD
2008-02-01
Trial end
2008-02-01
Status
Completed
Phase
Early phase I
Treatment
Chlorhexidine gluconate
Chlorhexidine gluconate (2% w/v) in an aqueous base. Administered topically.
Arms:
1
Other names:
ChloraPrep AQ
Povidone iodine
Povidone iodine scrub and paint. Administer topically.
Arms:
2
Other names:
Betadine
Size
122
Primary endpoint
3.0 log10 reduction in CFU/cm2 on inguinal sites, and 2.0 log10 reduction in CFU/cm2 on abdominal sites
10 minutes and 6 hours after application of test solutions
Eligibility criteria
Inclusion Criteria: * Free of dermatoses, cuts, lesions, or other skin disorders around test sites * must not have received topical or systemic antimicrobials, antibiotics, or steroids for 7 days prior to testing and agree to abstain from these materials until completion of the study Exclusion Criteria: * Exposure of test sites to antimicrobial agents, medicated soaps, medicated shampoos, or medicated lotions, use of biocide-treated pools or hot tubs, use of tanning beds, or sunbathing during the 7 day pre-test period or during the test period * exposure of the test sites to strong detergents, solvents, or other irritants during the 7 day pre-test period or during the test period * use of systemic or topical antibiotic medications, steroid medications, or any other product known to affect the normal microbial flora of the skin during the 7 day pre-test period or during the test period * known allergy to latex (rubber), alcohols, inks, or tape adhesives, or to common antibacterial agents found in soaps, lotions, or ointments, particularly chlorhexidine gluconate and povidone iodine * active skin rashes or breaks in the skin of the test sites * currently active skin disease or inflammatory skin condition, including contact dermatitis * showering or bathing within the 72 hour period prior to sampling * participation in a clinical study in the past 7 days or current participation in another clinical study
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE3'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'OTHER', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 122, 'type': 'ACTUAL'}}
Updated at
2023-07-12

1 organization

2 products

1 indication

Organization
CareFusion
Indication
Healthy